{"nct_id":"NCT03931291","title":"APR-246 in Combination With Azacitidine for TP53 Mutated AML (Acute Myeloid Leukemia) or MDS (Myelodysplastic Syndromes) Following Allogeneic Stem Cell Transplant","status":"COMPLETED","status_verified_date":"2025-03","start_date":"2019-09-16","start_date_type":"ACTUAL","primary_completion_date":"2021-08-27","primary_completion_date_type":"ACTUAL","completion_date":"2022-01-14","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["APRE"]}